CVRx, Inc. (CVRX)
0.541
+0.01
(+1.52%)
USD |
NASDAQ |
Nov 20, 11:00
CVRx Cash from Operations (Quarterly) : -10.90M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -10.90M |
| June 30, 2026 | -8.826M |
| March 31, 2026 | -12.16M |
| December 31, 2025 | -9.758M |
| September 30, 2025 | -9.709M |
| June 30, 2025 | -7.936M |
| March 31, 2025 | -12.77M |
| December 31, 2024 | -8.008M |
| September 30, 2024 | -10.41M |
| June 30, 2024 | -9.83M |
| March 31, 2024 | -10.90M |
| December 31, 2023 | -7.839M |
| September 30, 2023 | -8.125M |
| June 30, 2023 | -12.81M |
| Date | Value |
|---|---|
| March 31, 2023 | -10.25M |
| December 31, 2022 | -10.84M |
| September 30, 2022 | -11.10M |
| June 30, 2022 | -10.10M |
| March 31, 2022 | -10.64M |
| December 31, 2021 | -7.015M |
| September 30, 2021 | -9.215M |
| June 30, 2021 | -6.464M |
| March 31, 2021 | -5.038M |
| December 31, 2020 | -4.084M |
| September 30, 2020 | -5.157M |
| June 30, 2020 | -2.304M |
| March 31, 2020 | -4.551M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Stereotaxis, Inc. | -4.177M |
| Accuray, Inc. | -4.657M |
| Orthofix Medical, Inc. | 0.498M |
| ResMed, Inc. | 422.42M |
| Rockwell Medical, Inc. | -1.526M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.098M |
| Cash from Financing (Quarterly) | 5.155M |
| Free Cash Flow | -42.04M |
| Free Cash Flow Per Share (Quarterly) | -0.4035 |
| Free Cash Flow to Equity (Quarterly) | -10.99M |
| Free Cash Flow to Firm (Quarterly) | -9.388M |
| Free Cash Flow Yield | -272.8% |